Ishii, Takashi
Hamada, Kensuke
Jubishi, Daisuke
Hashimoto, Hideki
Okamoto, Koh
Hisasue, Naoko
Sunohara, Mitsuhiro
Saito, Minako
Shinohara, Takayuki
Yamashita, Marie
Wakimoto, Yuji
Otani, Amato
Ikeda, Mahoko
Harada, Sohei
Okugawa, Shu
Moriya, Kyoji
Yanagimoto, Shintaro
Article History
Received: 1 February 2023
Accepted: 2 June 2023
First Online: 13 June 2023
Competing interests
: Dr. Okamoto reports personal fees from AstraZeneca, Astellas Pharm, Sanyo Chemical, and Ono Pharmaceutical outside the submitted work. Dr. Hashimoto reports personal fees from Shionogi, MSD, ASAHI KASEI Pharm, bioMérieux Japan, and NISSUI PHARMACEUTICAL outside the submitted work. Dr. Harada reports personal fees from Shionogi, MSD, Daiichi Sankyo, and NISSUI PHARMACEUTICAL and grants from Shionogi outside the submitted work. Other authors have no conflict of interests.